Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee. Issue 1 (22nd September 2020)

• Record Type: Journal Article
• Authors: Theodoropoulos, Nicole M.; La Hoz, Ricardo M.; Wolfe, Cameron; Vece, Gabriel; Bag, Remzi; Berry, Gerald J.; Bucio, Jamie; Danziger‐Isakov, Lara; Florescu, Diana F.; Goldberg, David; Ho, Chak‐Sum; Lilly, Kathleen; Malinis, Maricar; Mehta, Aneesh K.; Nalesnik, Michael A.; Sawyer, Robert; Strasfeld, Lynne; Wood, R. Patrick; Michaels, Marian G.
• Is Part Of: Transplant infectious disease. Volume 23:Issue 1(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-09-22
• Subjects: donor‐derived transmission -- DTAC -- hepatitis B virus -- increased risk donors; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13458
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Hepatitis B virus (HBV) can be transmitted from organ donor to recipient, but details of transmission events are not widely published. The Disease Transmission Advisory Committee (DTAC) evaluated 105 cases of potential donor derived transmission events of HBV between 2009‐2017. Proven, probable or possible transmission of HBV occurred in 25 (23.8%) cases. Recipients of liver grafts were most commonly infected (20 of 21 exposed recipients) compared to 9 of 21 exposed non‐hepatic recipients. Eleven of 25 donors were HBV core antibody (HBcAb) positive/HBV surface antigen (HBsAg) negative and infected 8/20 recipients. Of the 10 liver recipients and 1 liver‐kidney recipient who received organs from these donors: six were not given antiviral prophylaxis, two developed infection after antiviral prophylaxis was discontinued, two developed HBV while on lamivudine prophylaxis, one was on antiviral prophylaxis and did not develop HBV viremia or antigenemia. One recipient of a HBcAb positive/HBsAg negative kidney developed active HBV infection. Unexpected donor‐derived transmission of HBV was a rare event in reports to DTAC, but was often detected in the recipient late post‐transplant. Six of 11 recipients (54.5%) of a liver from a HBcAb positive donor did not receive prophylaxis; all of these were potentially preventable with the use of anti‐viral prophylaxis.